Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro

The Journal of Antimicrobial Chemotherapy
H X XiaC O'morain

Abstract

Susceptibilities to clarithromycin and metronidazole of 444 Helicobacter pylori isolates cultured from antral biopsies of 444 dyspeptic patients were determined by disc diffusion tests (15 mu g disc for clarithromycin, 5 mu g disc for metronidazole). Susceptibility of 46 of these isolates to erythromycin (5 mu g disc) was also tested. Minimal inhibitory concentrations (MICs) of clarithromycin for 42 selected isolates were determined by a plate dilution method. A zone diameter of 30 mm was defined as a 'cut-off' size differentiating susceptibility and resistance of the organism to clarithromycin, by comparing results obtained with the two methods. Of the 444 isolates, 424 (95.5%) were highly sensitive to clarithromycin, with zone diameters ranging from 30 to 98 mm. Twenty isolates (4.5%) were defined as resistant to clarithromycin, with zone diameters ranging between 6 and 28 mm. The incidence of clarithromycin resistance was similar in men and women and in different age groups, and was not significantly different between patients with peptic ulcer and non-ulcer dyspepsia. Among the 444 isolates, 168 (37.8%) were metronidazole resistant. There was cross resistance between clarithromycin and erythromycin, but not between clarithr...Continue Reading

Citations

Mar 12, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E RozynekJ Jeljaszewicz
Feb 1, 1997·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·F SzczebaraM O Husson
Aug 15, 1996·FEMS Microbiology Letters·Y J Debets-OssenkoppC M Vandenbroucke-Grauls
Feb 24, 2001·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·A PilottoUNKNOWN Interdisciplinary Group for the Study of Ulcer
Jun 26, 1999·Alimentary Pharmacology & Therapeutics·M OkadaT Takata
Jan 13, 2000·Alimentary Pharmacology & Therapeutics·A GasbarriniG Gasbarrini
Mar 29, 2000·Alimentary Pharmacology & Therapeutics·F S LehmannC Beglinger
Apr 4, 2001·Alimentary Pharmacology & Therapeutics·M S OsatoD Y Graham
Jun 26, 2001·Symposium Series·J G Kusters, E J Kuipers
Oct 12, 2001·Journal of Gastroenterology and Hepatology·J YakoobZ Zhang
Aug 4, 1999·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·R J OwenD S Tompkins
Oct 6, 2000·The Journal of Antimicrobial Chemotherapy·T AlarcónM López-Brea
May 21, 2004·Journal of Gastroenterology and Hepatology·Javed YakoobZheng Zhang
Jun 27, 2000·Australian and New Zealand Journal of Medicine·A G FraserB Hollis
Dec 20, 2000·Antimicrobial Agents and Chemotherapy·B Vester, S Douthwaite
May 5, 2001·Expert Opinion on Pharmacotherapy·H H XiaS K Lam
Nov 12, 2013·Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology·Jacobo DibMaria E Cruz
Jun 26, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J YakoobZ Zhang
Oct 19, 2016·Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology·Adnan AbuhammourMohammed Zakaria
Jun 23, 1999·The Yale Journal of Biology and Medicine·J A Louw, I N Marks
Jul 9, 2014·Nature Reviews. Gastroenterology & Hepatology·Peter MalfertheinerMichael Selgrad
Sep 26, 2007·Journal of Medical Microbiology·Karen-Anja ModerBrigitte König
Jan 31, 2002·World Journal of Gastroenterology : WJG·Hua-Xiang XiaNicholas J Talley
Aug 21, 2002·Expert Opinion on Pharmacotherapy·Harry Hua-Xiang XiaShiu Kum Lam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.